Health Idea Now
Wednesday, 28 November 2018
U.S. FDA approves Catalyst Pharma's rare disease drug
The U.S. Food and Drug Administration approved on Wednesday Catalyst Pharmaceuticals Inc's drug to treat a rare autoimmune disease.
from Reuters: Health News https://ift.tt/2RlYlUO
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment